BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Skin cancer AND CBL, RNF55, 867, ENSG00000110395, C-CBL, CBL2 AND Diagnosis
11 results:

  • 1. Trends in incidence, treatment and survival of Merkel cell carcinoma in England 2004-2018: a cohort study.
    Mistry K; Levell NJ; Hollestein L; Wakkee M; Nijsten T; Knott CS; Steven NM; Craig PJ; Venables ZC
    Br J Dermatol; 2023 Feb; 188(2):228-236. PubMed ID: 36763882
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Systemic Mastocytosis: Advances in diagnosis and Current Management.
    Pullarkat ST; Wu W; Pullarkat V
    Cancer Treat Res; 2021; 181():167-178. PubMed ID: 34626361
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Diagnostic and prognostic value of heat shock protein 90α in malignant melanoma.
    Zhang T; Li Q; Zhang Y; Wang Q; Wang H; Gu K
    Melanoma Res; 2021 Apr; 31(2):152-161. PubMed ID: 33492051
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Association of Type of Treatment Facility With Overall Survival After a diagnosis of Head and Neck cancer.
    Carey RM; Fathy R; Shah RR; Rajasekaran K; Cannady SB; Newman JG; Ibrahim SA; Brant JA
    JAMA Netw Open; 2020 Jan; 3(1):e1919697. PubMed ID: 31977060
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [cancers in systemic sclerosis : risk factors, impact on survival and literature review].
    Catano J; Guedon A; Riviere S; Carrat F; Mahevas T; Fain O; Mekinian A
    Rev Med Interne; 2019 Oct; 40(10):637-644. PubMed ID: 31255252
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Serum exosomal microRNAs as potent circulating biomarkers for melanoma.
    Tengda L; Shuping L; Mingli G; Jie G; Yun L; Weiwei Z; Anmei D
    Melanoma Res; 2018 Aug; 28(4):295-303. PubMed ID: 29750752
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The Brazilian version of skindex-16 is a valid and reliable instrument to assess the health-related quality of life of patients with skin diseases.
    Cárcano CBM; de Oliveira CZ; Paiva BSR; Paiva CE
    PLoS One; 2018; 13(3):e0194492. PubMed ID: 29566036
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Head and neck nonmelanoma cutaneous malignancy treatment in a skin cancer referral center.
    Stathopoulos P; Igoumenakis D; Shuttleworth J; Frawley T; Ennis C; Battista E; Ameerally P
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2017 Feb; 123(2):183-187. PubMed ID: 27989709
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. De Novo Malignant Neoplasms in Renal Transplant Patients.
    Yılmaz Akçay E; Tepeoğlu M; Özdemir BH; Deniz E; Börcek P; Haberal M
    Exp Clin Transplant; 2016 Nov; 14(Suppl 3):100-105. PubMed ID: 27805524
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. ["De novo" malignant tumors in kidney transplant receptors].
    Robles JE; Aguera LG; Rosell D; Abad JI; Rodríguez-Rubio FI; Zudaire JJ; Errasti P; Berian JM
    Actas Urol Esp; 1994 Apr; 18(4):266-70. PubMed ID: 7976711
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Formalin-resistant leukocyte surface antigens in the diagnosis of cutaneous malignant lymphomas.
    Hauschild A; Sterry W
    Am J Pathol; 1989 Jul; 135(1):177-84. PubMed ID: 2774058
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.